New MACPAC Data on the Highly Effective Medicaid Drug Rebate Program
As I have previously explained, under the highly effective Medicaid Drug Rebate Program, drug manufacturers must provide substantial rebates to the federal government and states as a condition of having their drugs covered by Medicaid. The rebates apply to both fee-for-service and to managed care. A groundbreaking 2021 Congressional Budget Office study found that compared […]